Literature DB >> 7759484

Creatine kinase equilibration follows solution thermodynamics in skeletal muscle. 31P NMR studies using creatine analogs.

R W Wiseman1, M J Kushmerick.   

Abstract

The hypothesis tested was whether creatine kinase (CK) equilibrates with its substrates and products in the cytosol as if in solution. We used the creatine analogs cyclocreatine (cCr) or beta-guanidopropionate (beta GPA) to test if mass action ratios (gamma) for CK in muscle could be predicted from combined equilibrium constants (Kcomb) measured in solutions mimicking the intracellular environment. Mice were fed cCr or beta GPA and their muscles assayed for substrates and products of the CK reaction by 31P NMR spectroscopy and high performance liquid chromatography. After three weeks of feeding, gamma was indistinguishable from Kcomb in cCr-treated muscles demonstrating both PCr/Cr and phospho-analog/analog must have equilibrated with a constant and uniform cellular ATP/ADP ratio. In beta GPA-treated muscles, gamma was smaller than Kcomb due to a higher content of muscle beta GPA. Feeding beta GPA for 9-12 weeks resulted in a closer agreement between Kcomb and gamma, suggesting ATP/ADP ratios are not uniform within the muscle perhaps due to transient metabolic stress in some cells. From this analysis it follows that calculation of free ADP from the CK equilibrium for a heterogeneous population of cells with respect to total Cr and ATP content is correct only if chemical potentials of these cells are uniform.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7759484     DOI: 10.1074/jbc.270.21.12428

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

Review 1.  The Cardiome Project. An integrated view of cardiac metabolism and regional mechanical function.

Authors:  J B Bassingthwaighte; H Qian; Z Li
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

Review 2.  Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review.

Authors:  Yuchi Liu; Yuning Gu; Xin Yu
Journal:  Quant Imaging Med Surg       Date:  2017-12

3.  Blood flows and metabolic components of the cardiome.

Authors:  J B Bassingthwaighte; Z Li; H Qian
Journal:  Prog Biophys Mol Biol       Date:  1998       Impact factor: 3.667

Review 4.  31P-NMR-measured creatine kinase reaction flux in muscle: a caveat!

Authors:  T Wallimann
Journal:  J Muscle Res Cell Motil       Date:  1996-04       Impact factor: 2.698

5.  Theoretical modelling of some spatial and temporal aspects of the mitochondrion/creatine kinase/myofibril system in muscle.

Authors:  G J Kemp; D N Manners; J F Clark; M E Bastin; G K Radda
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

Review 6.  Functional aspects of the X-ray structure of mitochondrial creatine kinase: a molecular physiology approach.

Authors:  U Schlattner; M Forstner; M Eder; O Stachowiak; K Fritz-Wolf; T Wallimann
Journal:  Mol Cell Biochem       Date:  1998-07       Impact factor: 3.396

7.  Compartmentalized energy transfer in cardiomyocytes: use of mathematical modeling for analysis of in vivo regulation of respiration.

Authors:  M K Aliev; V A Saks
Journal:  Biophys J       Date:  1997-07       Impact factor: 4.033

8.  Phosphorus metabolite distribution in skeletal muscle: quantitative bioenergetics using creatine analogs.

Authors:  R W Wiseman; M J Kushmerick
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

9.  Presence of (phospho)creatine in developing and adult skeletal muscle of mice without mitochondrial and cytosolic muscle creatine kinase isoforms.

Authors:  H J A in 't Zandt; A J C de Groof; W K J Renema; F T J J Oerlemans; D W J Klomp; B Wieringa; A Heerschap
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

10.  Metabolic compartmentation - a system level property of muscle cells: real problems of diffusion in living cells.

Authors:  Valdur Saks; Nathalie Beraud; Theo Wallimann
Journal:  Int J Mol Sci       Date:  2008-05-09       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.